Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10374	Companies
216208	Keywords
145902	Articles
114471	Press releases

Home
Companies
Jaguar Health, Inc.

BRIEF

published on 01/08/2025 at 14:35, 1 year 4 months ago

Jaguar Health participera aux prochains événements destinés aux investisseurs

Médicaments Santé Jaguar Discussion Au Coin Du Feu Vitrine Biotechnologique Événements Pour Les Investisseurs
PRESS RELEASE

published on 01/08/2025 at 14:30, 1 year 4 months ago

Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase
Jaguar Health, Inc. to participate in virtual fireside chat and in-person presentation at upcoming healthcare events. Focus on developing medicines from rainforest plants

Pharmaceuticals Jaguar Health Rainforest Plants Virtual Fireside Chat Healthcare Events
BRIEF

published on 01/07/2025 at 16:05, 1 year 4 months ago

Magdalena Biosciences Set to Present at Neuroscience Innovation Forum

ADHD Magdalena Biosciences Schizophrenia Botanical Drugs MB2500
BRIEF

published on 01/07/2025 at 16:05, 1 year 4 months ago

Magdalena Biosciences s'apprête à présenter son projet au Forum d'innovation en neurosciences

Médicaments Botaniques Schizophrénie Biosciences De Magdalena MB2500 TDAH
PRESS RELEASE

published on 01/07/2025 at 16:00, 1 year 4 months ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum
Magdalena plans to file IND for new psychoactive drug in 2025 for mental health, focusing on ADHD and schizophrenia. Potential paradigm shift in plant-based drug development

ADHD Schizophrenia IND Application Magdalena Psychoactive Drug
BRIEF

published on 12/19/2024 at 15:05, 1 year 4 months ago

Jaguar Health's Joint Venture Imports Coca Leaf for Mental Health Research

Jaguar Health Botanical Drugs Coca Leaf Import Mental Health Research ADHD Treatments
BRIEF

published on 12/19/2024 at 15:05, 1 year 4 months ago

La coentreprise de Jaguar Health importe des feuilles de coca pour la recherche sur la santé mentale

Santé Jaguar Médicaments À Base De Plantes Importation De Feuilles De Coca Recherche Sur La Santé Mentale Traitements Du TDAH
PRESS RELEASE

published on 12/19/2024 at 15:00, 1 year 4 months ago

Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications
Magdalena explores coca leaf's therapeutic benefits for ADHD and neuropsychiatric indications in partnership with Peru. Jaguar's Dr. King to present at Wisdom of the Leaf Coca Summit on coca-based Botanical Drugs

ADHD Peru Botanical Drugs Magdalena Coca Leaf
BRIEF

published on 12/18/2024 at 16:05, 1 year 4 months ago

Jaguar Health Launches Phase 2 Study for Microvillus Inclusion Disease

Crofelemer Jaguar Health Orphan-Drug Designation Phase 2 Study MVID
BRIEF

published on 12/18/2024 at 16:05, 1 year 4 months ago

Jaguar Health lance une étude de phase 2 sur la maladie d'inclusion des microvillosités

Crofelemer Désignation De Médicament Orphelin Étude De Phase 2 Santé Jaguar MVID

Accesswire

Published on 05/09/2026 at 01:55, 2 days 5 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 2 days 5 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 2 days 5 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 7 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 2 days 8 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/11/2026 at 07:11, 12 minutes ago

ams-OSRAM AG: Convocation of the Annual General Meeting 2026
Published on 05/11/2026 at 07:10, 13 minutes ago

Readcrest Capital realigns its construction project in Halle
Published on 05/11/2026 at 07:10, 13 minutes ago

Hypoport delivered gross profit growth and a marked increase in EBIT at the start of 2026.
Published on 05/11/2026 at 07:08, 15 minutes ago

EQS-Adhoc: ams-OSRAM AG: ams OSRAM has published the proposals for the Annual General Meeting 2026
Published on 05/11/2026 at 07:00, 23 minutes ago

Aurubis AG: Aurubis delivers improved performance: Increased quarterly result and higher forecast

Les Echos

Published on 05/07/2026 at 19:15, 3 days 12 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 12 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 12 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 12 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 12 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE